Asymmetric reduction method

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7847107
APP PUB NO 20090043110A1
SERIAL NO

12087092

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is to provide a novel method for producing (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionic acid which is useful as a therapeutic agent for diabetes. The present invention relates to a method for producing (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionic acid, which is characterized in that 2-benzylidene-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionic acid is subjected to a catalytic reduction reaction in the presence of an asymmetric catalyst prepared from a pyrrolidinebisphosphine compound (I) represented by the following general formula (I):independently represent an optionally substituted aryl group. The * mark in the pyrrolidine ring shows that the carbon atom at that position has the S configuration, and a rhodium compound.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KISSEI PHARMACEUTICAL CO LTD19-48 YOSHINO MATSUMOTO-SHI NAGANO 3998710 ?3998710

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Matsumoto, Yoshinori Toyama, JP 49 238
Takeuchi, Yuki Takaoka, JP 14 9
Yamamoto, Hiroyuki Niigata, JP 339 6151

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation